Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Braxia Scientific Corp C.BRAX

Alternate Symbol(s):  BRAXF

Braxia Scientific Corp. is a Canada-based medical research and telemedicine company with a clinic that provide ketamine treatments for persons with depression and related disorders. Through its medical solutions, it intends to reduce the illness burden of brain-based disorders, such as major depressive disorder, among others. The Company is primarily focused on owning and operating multidisciplinary clinics, providing treatment for mental health disorders, and research activities related to discovering and commercializing novel drugs and delivery methods. It seeks to develop ketamine and derivatives and other psychedelic products from its IP development platform. The Company has clinic operations in the Canadian cities of Mississauga, Kitchener-Waterloo, Ottawa and Montreal. Its subsidiary, Braxia Health, is engaged in offering rapid onset treatments to aid those suffering from several treatment-resistant conditions, such as depression and bipolar disorder.


CSE:BRAX - Post by User

Post by TomConstantineon Oct 09, 2021 8:42am
347 Views
Post# 33991613

Agra Ventures Derivative Action - Coming Full Circle

Agra Ventures Derivative Action - Coming Full Circle The Birdsalls and Their Companies 87. Lucas Birdsall has been called a purported consultant or strategic advisor to Agra, as well as represented by Transnational to be a consultant to Transnational. 88. William Gareth Birdsall is Lucas Birdsalls younger brother. He is the former CEO and director of Braxia Scientific Corp., whose board of directors was comprised of current Agra directors Joseph Perino and Jerry Habuda, as well as Defendant Matthew Fish. 89. 1132902 B.C. Ltd. is a company incorporated on September 5, 2017, that is owned by and/or under the control of Lucas Birdsall. 1132902 B.C. Ltd. was represented to be a consultant to all of Transnational, Powertap, and Agra, and received hundreds of thousands of Powertap, Agra and Transnational securities as consulting or finders fees in relation to various sham transactions explicated below. For example, 1132902 B.C. Ltd. was granted 5.45 million Agra options on August 1, 2019 (and 6.45 million Agra options just between August 1, 2018 to August 1, 2019) for supposed consulting work. 90. Additionally, 1132902 B.C. Ltd. was also part owner of Eurasia Infused Cosmetics Inc. (acquired by Agra on August 19, 2019). 1132902 B.C. Ltd. further received a bonus from Agra of 1 million Agra shares with a value of $190,000 with regards to the performance of Canutra Naturals Ltd. on November 15, 2019 (despite Cantura Naturals Ltd. being represented by Agra itself as having a value of $nil). 91. Intercontinental Advisory Corp. is a company that was incorporated under the BCBCA on May 8, 2018, which is owned by and/or under the power and control of William Gareth Birdsall. Intercontinental Advisory Corp is a purported agent or consultant to Powertap and received a $250,950 finders fee in connection with Powertaps acquisition of 11353675 Canada Corp."
<< Previous
Bullboard Posts
Next >>